Clinical trial

Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

NCT00899145

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2008-05-01

PhaseN/A

Study timeline

Study start (unknown)2008-05-01Date precision: month

Registry last updated2017-07-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

BRCA1 Mutation Carrierunresolved

BRCA2 Mutation Carrierunresolved

Breast Carcinomaunresolved

Interventions

Laboratory Biomarker AnalysisOTHER

Sponsors & collaborators

Gynecologic Oncology Grouplead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00899145 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.